BIS Research ( Business Intelligence and Strategy Research)

  North America currently holds the largest market share in terms of revenue generation. North America interventional oncology devices market was valuedat$965.90million in 2018. High prevalence of cancer, growing geriatric population, and high reimbursement rates are the prominent factors propelling the growth of the North America interventional oncology devices market. However, the market for interventional oncology devices market in Asia-Pacific is anticipated to witness the highest growth rate during the forecast period. The massive demand for interventional oncology devices, large geriatric population base, demand for minimally invasive and non-invasive surgical procedures, and high prevalence rates of cancer, is the leading contributor to the growth of the Asia-Pacific interventional oncology devices market. The interventional oncology devices market in economies such as Japan, China, India, and South Korea, among others possesses significant scope for the expansion of operation

  Nucleic acid isolation and purification is the preliminary step in the field of molecular biology research accompanied with recombinant techniques. The nucleic acid isolation process majorly includes enzymatic digestion and mechanical and chemical disruption. On the other hand, purification consists of the combination of precipitation, chromatography, centrifugation, electrophoresis, and separation. The process of nucleic acid isolation aids sample processing by reducing the time, significantly minimizes nucleic acid loss, and enhances experimental process efficiency and effectiveness. The obtained purified product is further used in recombinant technology methods, thereby making it suitable for targeted purposes in the field of omics research. The advantages offered by nucleic acid isolation and purification significantly aid scientists and researchers to obtain high-quality starting material for conducting downstream applications, thereby generating accurate results. According

  In-silico drug discovery methods can help in identifying drug targets via bioinformatics tools. In addition, the methods can also be used to analyze the target structures for possible binding active sites. The use of computational methods and computers have permeated all aspects of drug discovery and drug design. The methods are facilitating the access of massive amounts of data generated and transforming the extensive complex biological data into useful knowledge for the drug discovery process. These computational tools offer the advantage of delivering new drug candidates more quickly and at a lower cost.   According to the market intelligence report published by BIS Research, the in-silico drug discovery market is projected to grow at a significant CAGR of 12.92%, during the forecast period, 2019-2029. The global in-silico drug discovery market is undergoing a significant change with regard to the advancements that have already taken place and are currently invading the mark

  North America currently holds the largest market share in terms of revenue generation. North America interventional oncology devices market was valuedat$965.90million in 2018. High prevalence of cancer, growing geriatric population, and high reimbursement rates are the prominent factors propelling the growth of the North America interventional oncology devices market. However, the market for interventional oncology devices market in Asia-Pacific is anticipated to witness the highest growth rate during the forecast period. The massive demand for interventional oncology devices, large geriatric population base, demand for minimally invasive and non-invasive surgical procedures, and high prevalence rates of cancer, is the leading contributor to the growth of the Asia-Pacific interventional oncology devices market. The interventional oncology devices market in economies such as Japan, China, India, and South Korea, among others possesses significant scope for the expansion of operation

  Nucleic acid isolation and purification is the preliminary step in the field of molecular biology research accompanied by recombinant techniques. The nucleic acid isolation process majorly includes enzymatic digestion and mechanical and chemical disruption. On the other hand, purification consists of a combination of precipitation, chromatography, centrifugation, electrophoresis, and separation. The process of nucleic acid isolation aids sample processing by reducing the time, significantly minimizes nucleic acid loss, and enhances experimental process efficiency and effectiveness. The obtained purified product is further used in recombinant technology methods, thereby making it suitable for targeted purposes in the field of omics research. The advantages offered by nucleic acid isolation and purification significantly aid scientists and researchers to obtain high-quality starting material for conducting downstream applications, thereby generating accurate results. According to t

  An increasing demand from clinicians for the electronic collection of cancer-related data has led to the electronic collection of data that can efficiently facilitate personalized care for patients and catalyze real-time clinical research studies. The importance of EHR (for electronic collection of data) has been recognized by organizations, such as the American Society of Clinical Oncology (ASCO). In 2010, ASCO released the final draft of the Certification Commission for Health Information Technology (CCHIT) criteria for the oncology EHR certification for the EHR vendors. Under oncology informatics, the products are highlighted to cover the complete treatment process. Information is collated from different medical specialties, such as surgery, chemotherapy, pathology, and radiotherapy. There are various forms of specialist oncology information systems aimed at identifying common processing across tumor streams. Following are the several information systems included in oncology

  Robotic surgery consumables may be defined as those instruments and accessories which are used with computer-assisted surgical systems. The equipment help the surgeons perform safe, precise, and accurate surgical procedures. Robotic surgery consumables include instruments such as scissors, forceps, and other tools. These instruments, in most cases, are specially manufactured by surgical robotic system manufacturers. The instruments are designed in such a manner that they are able to perform a safe and minimally invasive surgical (MIS) procedure. Certain consumables, such as graspers and forceps, can be reused. They can be re-used for more than one surgery. However, they must be replaced after a certain number of procedures have been performed, as per specifications provided by the original equipment manufacturer (OEM). The global robotic surgery consumables market is estimated to be valued at $2,831.7 million in 2019 and is projected to register a CAGR of 11.37%. The growth in t

  Technological advancements in the healthcare industry have always played a crucial role in its overall development. The recent advancements in the life science industry, such as wearable healthcare devices, sequencing technologies, regenerative medicine, and genomic technologies, supported by breakthroughs in the field of genome sequencing, and molecular research, have opened up new and promising pathways to combat genetic diseases and reduce the overall global economic burden. Several conglomerate companies and start-ups, including Illumina, Inc., F. Hoffmann-La Roche AG, and Diagnomics Inc. based in the developed countries, such as the U.S., the U.K., Germany, China, France, and Canada have been making significant investments in the fields of life sciences to develop promising gene sequencing-based non-invasive diagnostic procedures to promote global health. Among the innumerable advancements witnessed by the industry, non-invasive prenatal testing (NIPT) today stands as one of the

  Autonomy in micro-mobility is still a far-fetched concept; however, some technology companies, such as Marble, have been successful in deploying projects in the last-mile delivery market. Micro-mobility is a part of the global mobility-as-a-service market. The micro-mobility ecosystem is currently attracting a substantial sum of investments in the mobility service domain. Amount of traveling via micro-mobility more than doubled in 2018 in comparison to 2017. The growth rate in micro-mobility is currently higher than the car-sharing and ride-hailing services. This has pushed the major travel companies, engaging in ride-hailing initiatives, to re-strategize and integrate micro-mobility in their service portfolio. The benefits of micro-mobility are based upon certain criteria which are further divided by power sources, i.e., gasoline and electric. BIS Research Report on Micro Mobility Market Gasoline-powered mode: Cost of device or vehicle is the average selling price of various

  A vector itself is a DNA molecule, consisting of an insert (transgene) and a larger sequence that serves as the pillar of the vector. The main role of the vector in transferring genetic information to another cell involves isolation, multiplication, or expression of the insert in the target cell. Viral and non-viral vectors are the two types of vectors. Viral vectors are genetically engineered viruses that are used by molecular biologists as a carrier for the transmission of the genetic material to living organisms and in-vitro cell culture. Types of the viral vectors or choice of the virus depend upon several factors, including the size of the exogenous gene (transgene), stability and longevity of the transgene, the expression of the living cell, the types of the cell, transgene expression, and stability of the cell, among others. Adeno-associated virus, lentivirus, adenoviruses (Ads), retroviruses, poxviruses, baculoviruses, and herpes simplex viruses are some of the common types

  Drug discovery is used for the identification of the lead structure, which is followed by the synthesis of its analogs, and the latter’s screening to get candidate molecules for drug development. The objective of the drug discovery process is to search for new drug molecules that can bind to a specific target. Further, in the traditional drug discovery process, identifying the suitable drug target is the first and foremost task. The different steps associated with the in-silico drug discovery process include target identification, target validation, lead identification, lead optimization, pre-clinical studies, and clinical trials. The market for in-silico drug discovery is focused on software, services, and artificial intelligence. Advanced software and informatics deliver far more insight than traditional methods, with a resolution significantly higher than ever before. According to the market study published by BIS Research, the in-silico drug discovery market was estimated at

  According to a new market intelligence report by BIS Research titled ‘ Global IoT Chip Market − Analysis and Forecast, 2019-2029’ , the IoT chip market is anticipated to grow at a CAGR of 15.18% during the forecast period 2019-2029. BIS Research Report: https://bisresearch.com/industry-report/iot-chip-market.html     Attributed to the strong presence of emerging economies, Asia-Pacific is expected to generate the maximum revenue in the global Internet of Things (IoT) chip market. The region generated revenue of $2.75 Billion in the year 2018 and is expected to account for $19.28 Billion by the end of the year 2029. Along with intense adoption rate of advanced technologies, the region is expected to witness highest market growth of CAGR 19.47%. China contributed majority of the revenue in the region.   About BIS Research: BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynami

  According to a new market intelligence report by BIS Research titled ‘ Global Electric Vehicle Fast-Charging System Market − Analysis and Forecast, 2020-2025 ’ ,   The electric vehicle fast charging system market is anticipated to grow at a CAGR of 21.90% during the forecast period 2019-2029. BIS Research Report: https://bisresearch.com/industry-report/global-electric-vehicle-fast-charging-system-market.html   The electric light duty vehicle segment dominated the global electric vehicle fast charging system market and is anticipated to maintain its dominance throughout the forecast period (2019-2029). This is mainly due to a rise in the number of electric passenger vehicles, such as electric cars, vans, and pick-up trucks, which further boosts the demand for fast charging system. Additionally, governments of numerous countries are creating policies and taking initiatives to increase the deployment rate for electric vehicles. Moreover, governments are also focusing for the deplo

  Currently, the Internet of Things (IoT) is observed revolutionizing chip making designs worldwide and simultaneously creating lucrative opportunities for chipmakers. A fundamental IoT chip comprises sensors, connectivity integrated circuits, micro-controlling units, and various categories of memories. It can be termed as a minute electronic device implanted on machines, objects, and a variety of consumer devices. Furthermore, IoT chips are engineered for extensive durability to serve the purpose for a decade, to justify technology cost. In this era of continuous technological upgradation, IoT chips are embedded for diversified applications and behold the potential of maintaining communication among millions of internet-connected smart devices. These chipsets can function on Android, Microsoft Windows, as well as on Linux. According to a market study by BIS Research, the global IoT chip market generated a revenue of $8.33 billion in 2018 and is expected to witness a CAGR of 15.18

  Oil and gas is an enormous industry that includes three major sectors, i.e., upstream, midstream, and downstream. Each sector focuses on key aspects of the oil and gas industry, such as exploration and production, drilling, transportation, and sales. The increasing usage of IoT solutions in the oil and gas industry is expected to help the companies in analyzing data, making more accurate decisions, and lowering the operational cost. The oil and gas industry is gradually adopting new technologies in its expedition to be more efficient and profitable with low margins, and the Internet of Things (IoT), artificial intelligence (AI), and cognitive computing are the best solutions to it. Since 2013, with the use of advanced sensors and IoT solutions, companies are able to store a large amount of data and output real-time responses based on that data. In the near future, IoT is expected to include more than trillion sensors used to generate and share data, which will help the oil and gas

  Advancements in the field of molecular biology and technical engineering have improved the diagnostics methods and results for microfluidics market. The rise of micro-electrochemical systems (MEMS) fluidics devices has led to the development of lab-on-a-chip devices, fuel cells, drug delivery devices, and rapid diagnostics. Microfluidics has regularly been proclaimed as a distinct advantage in life sciences research and industry. The microfabrication technologies have disseminated to various fields such as flow cytometry, point-of-care diagnostics, stem cell biology, cell analysis and reproductive biology. The main advantages of microfluidics-based point-of-care technology (POCT) include the portability of POCT devices and their delivery of quick and accurate results. This is opposed to the traditional diagnostics tests that require transport of the specimen away from the patient and execution of the tests in medical laboratories taking hours or to establish. With the continuous

  Over the past five years, the financial service industry has witnessed far-reaching technology-led transformations, with companies looking for improving the efficiency of their financial departments by incorporating innovative IT solutions. The banking software industry has witnessed significant developments in the past decade, in terms of understanding, exploring, researching, managing, and utilizing resources to create value. A similar trend is expected to prevail in the next decade, and the banking software industry is expected to evolve in terms of facilitating global, multi-service, low-cost, and digital banking. However, over the past decade, significant threats of terrorism from money laundering have become a major concern for regulatory bodies such as Financial Crimes Enforcement Network (FinCEN) and Financial Action Task Force (FATF). Therefore, with the growth in the banking software industry, there is an increasing demand for regulators, such as anti-money laundering (AML)

  According to a new market intelligence report by BIS Research titled ‘ Global DNA Damage Response Drugs Market − Analysis and Forecast, 2020-2030 ’ , the global DNA damage response drugs market was estimated to be $3.59 Billion in 2020 and is expected to reach $24.84 Billion by the end of 2030, growing at a CAGR of 21.33%during the forecast period. BIS Research Report: https://bisresearch.com/industry-report/dna-damage-response-drugs-market.html   The North America region is expected to dominate the global DNA damage response drugs market during the forecast period, 2020-2030. The growing need to develop novel treatment options for cancer, increasing pharmaceutical R&D expenditure, rising research in the field of oncology, and growing prevalence of cancer are some of the underlying factors responsible for the growth of the North America DNA damage response drugs market. Also, the presence of major market players has contributed significantly to the large share of the North

  According to a new market intelligence report by BIS Research titled ‘ Global Silicon Photonics Market − Analysis and Forecast, 2019-2025 ’ , the global silicon photonics market was estimated to be $520.0 Million in 2019 and is expected to reach $3.07 Billion by the end of 2025, growing at a CAGR of 33.95% during the forecast period. BIS Research Report: https://bisresearch.com/industry-report/silicon-photonics-market.html In terms of regional demand, North America and Europe together hold more than 60% of the total market share. The dominance of North America is attributable to the increasing adoption of silicon photonic products across the data communication and telecommunication industries. China also holds a notable share in the silicon photonics market in terms of revenue generation due to strong focus on research and development, well-established closed knit supply chain, and the massive growth in emerging end-use markets in China. The rapid growth in India is attributed